1. Home
  2. MNDR vs GNPX Comparison

MNDR vs GNPX Comparison

Compare MNDR & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNDR
  • GNPX
  • Stock Information
  • Founded
  • MNDR 2016
  • GNPX 2009
  • Country
  • MNDR Singapore
  • GNPX United States
  • Employees
  • MNDR N/A
  • GNPX N/A
  • Industry
  • MNDR
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MNDR
  • GNPX Health Care
  • Exchange
  • MNDR Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • MNDR 9.3M
  • GNPX 9.4M
  • IPO Year
  • MNDR 2024
  • GNPX 2018
  • Fundamental
  • Price
  • MNDR $3.80
  • GNPX $0.20
  • Analyst Decision
  • MNDR
  • GNPX
  • Analyst Count
  • MNDR 0
  • GNPX 0
  • Target Price
  • MNDR N/A
  • GNPX N/A
  • AVG Volume (30 Days)
  • MNDR 273.7K
  • GNPX 4.2M
  • Earning Date
  • MNDR 11-16-2025
  • GNPX 11-12-2025
  • Dividend Yield
  • MNDR N/A
  • GNPX N/A
  • EPS Growth
  • MNDR N/A
  • GNPX N/A
  • EPS
  • MNDR N/A
  • GNPX N/A
  • Revenue
  • MNDR $11,600,567.00
  • GNPX N/A
  • Revenue This Year
  • MNDR $188,831.77
  • GNPX N/A
  • Revenue Next Year
  • MNDR $76.44
  • GNPX N/A
  • P/E Ratio
  • MNDR N/A
  • GNPX N/A
  • Revenue Growth
  • MNDR 0.61
  • GNPX N/A
  • 52 Week Low
  • MNDR $3.33
  • GNPX $0.14
  • 52 Week High
  • MNDR $40.00
  • GNPX $3.97
  • Technical
  • Relative Strength Index (RSI)
  • MNDR 68.96
  • GNPX 49.27
  • Support Level
  • MNDR $3.70
  • GNPX $0.16
  • Resistance Level
  • MNDR $3.93
  • GNPX $0.22
  • Average True Range (ATR)
  • MNDR 0.32
  • GNPX 0.02
  • MACD
  • MNDR 0.07
  • GNPX -0.00
  • Stochastic Oscillator
  • MNDR 79.51
  • GNPX 44.32

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: